Seman et al. analyzed DNA methylation alterations in the SLC30A8 promoter in peripheral blood from a large Malay population and identified hypermethylation of five CpG sites in patients with T2D compared to controls (48). The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.